We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
PriceSmart's April Comps Rise 1.9%, Stock Down 8% in a Month
Read MoreHide Full Article
PriceSmart, Inc. (PSMT - Free Report) has been witnessing robust sales performance for a while now despite an evolving retail landscape. The company’s net sales rose 1.6% year over year to $240.3 million for April, following increase of 8.9%, 6.6% and 6.2% in March, February and January, respectively.
Also, comparable warehouse club sales rose 1.9% for the four weeks (ended Apr 29, 2018). Comps grew 3.5%, 4.4% and 0.5% for March, February and January, respectively. Comparable warehouse club sales were up 2.7% for the 34-week period (ended Apr 29, 2018) compared with the year-ago period.
For the 8 weeks ending Apr 29, 2018, comparable warehouse club sales increased 2.7%. The 8-week period was taken into consideration due to the shift of Easter from April to March in 2018, unlike the previous year, to analyze performance better.
On May 3, PriceSmart introduced a warehouse club in Santo Domingo, Dominican Republic, marking its fourth club in the country. This brings the total company’s warehouse clubs in operation to 41.
Notably, retail sector has long been bearing the brunt of changing consumer preferences from offline shopping to online, alongside lower store traffic and volatile consumer spending. Consequently, retailers are focusing more on enhancing their omni-channel capabilities, optimizing store fleet and restructuring activities to counter these headwinds.
Such woes in the retail space have weighed on PriceSmart’s results as evident from its dismal surprise history. PriceSmart delivered in-line earnings in the last reported quarter after three straight misses. In the trailing four quarters, the company pulled off an average negative earnings surprise of 7.1%.
These concerns have also hurt investors’ sentiments. Consequently, this Zacks Rank #4 (Sell) company underperformed the industry in a month’s time. The stock has lost 7.8% against the industry’s breakeven.
Apart from PriceSmart, retailers like L Brands, Inc. (LB - Free Report) , Zumiez Inc. (ZUMZ - Free Report) and Costco Wholesale Corporation (COST - Free Report) recently released sales data for April. While L Brands reported flat comps year over year, Zumiez and Costco continued with their favorable comps trend, gaining 1.7% and 10.9%, respectively. In fact, Zumiez reported comps growth for the 14th straight month.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
PriceSmart's April Comps Rise 1.9%, Stock Down 8% in a Month
PriceSmart, Inc. (PSMT - Free Report) has been witnessing robust sales performance for a while now despite an evolving retail landscape. The company’s net sales rose 1.6% year over year to $240.3 million for April, following increase of 8.9%, 6.6% and 6.2% in March, February and January, respectively.
Also, comparable warehouse club sales rose 1.9% for the four weeks (ended Apr 29, 2018). Comps grew 3.5%, 4.4% and 0.5% for March, February and January, respectively. Comparable warehouse club sales were up 2.7% for the 34-week period (ended Apr 29, 2018) compared with the year-ago period.
For the 8 weeks ending Apr 29, 2018, comparable warehouse club sales increased 2.7%. The 8-week period was taken into consideration due to the shift of Easter from April to March in 2018, unlike the previous year, to analyze performance better.
On May 3, PriceSmart introduced a warehouse club in Santo Domingo, Dominican Republic, marking its fourth club in the country. This brings the total company’s warehouse clubs in operation to 41.
Notably, retail sector has long been bearing the brunt of changing consumer preferences from offline shopping to online, alongside lower store traffic and volatile consumer spending. Consequently, retailers are focusing more on enhancing their omni-channel capabilities, optimizing store fleet and restructuring activities to counter these headwinds.
Such woes in the retail space have weighed on PriceSmart’s results as evident from its dismal surprise history. PriceSmart delivered in-line earnings in the last reported quarter after three straight misses. In the trailing four quarters, the company pulled off an average negative earnings surprise of 7.1%.
These concerns have also hurt investors’ sentiments. Consequently, this Zacks Rank #4 (Sell) company underperformed the industry in a month’s time. The stock has lost 7.8% against the industry’s breakeven.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Apart from PriceSmart, retailers like L Brands, Inc. (LB - Free Report) , Zumiez Inc. (ZUMZ - Free Report) and Costco Wholesale Corporation (COST - Free Report) recently released sales data for April. While L Brands reported flat comps year over year, Zumiez and Costco continued with their favorable comps trend, gaining 1.7% and 10.9%, respectively. In fact, Zumiez reported comps growth for the 14th straight month.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>